---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-24-002424"
form_type: "8-K"
ticker: "UFPT"
cik: "0000914156"
company_name: "UFP TECHNOLOGIES INC"
filed_at: "2024-05-01T23:59:59+00:00"
generated_at: "2026-06-03T03:46:06.694460+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# UFP Technologies Q1 net income up 30% to $12.7M; EPS $1.64; sales $105M (+7.4%)

## Summary
- Diluted EPS of $1.64 vs $1.27 in Q1 2023; net income $12.7M vs $9.7M.
- Revenue $105.0M, up 7.4% YoY; medical market sales $90.0M (+7.4%); other markets $15.0M (+7.4%).
- Operating income grew 24% to $15.9M; adjusted EBITDA $20.7M (+6.5%); gross margin 28.6% (down from 29.4%).
- CEO cites growth in robotic surgery and infection prevention; Mexico sales up 47%; Dominican Republic expansion complete.
- Balance sheet with ~$34M debt; active acquisition pipeline with multiple projects in due diligence.

## SEC filing metadata
- accession: 0001171843-24-002424
- form_type: 8-K
- ticker: UFPT
- cik: 0000914156
- company_name: UFP TECHNOLOGIES INC
- filed_at: 2024-05-01T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/914156/000117184324002424/0001171843-24-002424-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/914156/000117184324002424/f8k_050124.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-24-002424
- JSON: https://secwatch.observer/filing/0001171843-24-002424.json
- Plain text: https://secwatch.observer/filing/0001171843-24-002424.txt

## Key facts
- Earnings Releases
  UFP TECHNOLOGIES INC reported first quarter ended March 31, 2024 results: revenue $105.0 million, net income $12.7 million, EPS $1.64 per diluted common share outstanding.
  - Period: first quarter ended March 31, 2024
  - Revenue: $105.0 million
  - Net income: $12.7 million
  - EPS: $1.64 per diluted common share outstanding
  - Result: reported results
  source text: UFP Technologies, Inc. (Nasdaq: UFPT), a designer and custom manufacturer of comprehensive solutions primarily for the medical market, today reported net income of $12.7 million or $1.64 per diluted common share outstanding for its first quarter ended March 31, 2024, compared to net income of $9.7 million or $1.27 per diluted common share outstanding for the first quarter of 2023. Net Sales for the first quarter were $105.0 million compared to 2023 first quarter sales of $97.8 million.
  evidence_url: https://www.sec.gov/Archives/edgar/data/914156/000117184324002424/0001171843-24-002424-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.